Researchers discover key to drug resistance in common breast cancer treatment

Scientists from the Florida campus of The Scripps Research Institute (TSRI), the University of California (UC), San Diego and the University of Illinois have found that two immune system molecules may be key to the development of drug resistance in estrogen-driven breast cancers. …read more

Source: EurekAlert

(Visited 2 times, 1 visits today)

Popular Posts